{"SPADE_UN_13445": {"Clinical Information": [], "Patent Information": [], "Sequence Information": {"SPADE ID": "SPADE_UN_13445", "Peptide Name": "CPF-13 (Variant of CPF-C1)", "Source": "Synthetic construct", "Family": "Not found", "Gene": "N/A", "Sequence": "GFGSLLGKALRLWKKVL", "Sequence Length": 17, "UniProt Entry": "No entry found", "Protein Existence": "Synthetic form", "Biological Activity": ["Antimicrobial", "Antibacterial", "Anti-Gram+"], "Target Organism": "[Ref.32590058] Gram-positive:S. aureus ATCC 25923 (MIC = 4 μg/mL, MIC = 8 μg/mL in 10% serum, MIC = 4 μg/mL in 150 mM, MBIC50 = 4 μg/mL, MBIC90 = 8 μg/mL, MBEC = 8 μg/mL), MRSA ATCC 33591 (MIC = 8 μg/mL), MRSA 054 isolated from clinics (MIC = 8 μg/mL), MRSA 023 isolated from clinics (MIC = 8 μg/mL), MRSA 113 isolated from clinics (MIC = 8 μg/mL), MRSA 048 isolated from clinics (MIC = 8 μg/mL), MRSA 002 isolated from clinics (MIC = 8 μg/mL), MRSA 074 isolated from clinics (MIC = 8 μg/mL), MRSA 051 isolated from clinics (MIC = 8 μg/mL), MRSA 052 isolated from clinics (MIC = 8 μg/mL), MRSA 075 isolated from clinics (MIC = 8 μg/mL), MRSA 071 isolated from clinics (MIC = 8 μg/mL), MRSA 936 isolated from clinics (MIC = 8 μg/mL), S. aureus 725 (MIC = 8 μg/mL), S. aureus 794 (MIC = 8 μg/mL)", "Hemolytic Activity": "[Ref.32590058]It showed significant toxicity at high concentrations. At the concentration of 16, 32, 64 and 128 μg/mL, CPF-13 displayed 2%, 10%, 72% and 72% hemolysis, respectively.", "Cytotoxicity": "Not found", "Binding Target": "Bacterial membrane", "Linear/Cyclic": "Linear", "N-terminal Modification": "Free", "C-terminal Modification": "Amidation", "Stereochemistry": "L", "Structure Description": "Not found", "Formula": "C91H152N24O19", "Mass": 1886.33, "PI": 11.26, "Net Charge": 4, "Hydrophobicity": 0.51, "Half Life": "Mammalian:30 hourYeast:>20 hourE.coli:>10 hour", "Comments": "CPF-13 showed improved antimicrobial activities against S. aureus and stabilities in serum and salt solution.", "Literature": [{"Title": "CPF-C1 analog with effective antimicrobial and antibiofilm activities against Staphylococcus aureus including MRSA", "Pubmed ID": "32590058", "Reference": "Biochimie. 2020 Sep;1761-11. doi 10.1016/j.biochi.2020.06.003. Epub 2020 Jun 23.", "Author": "Xie J, Li Y, Guo X, Rao J, Yan T, Mou L, Wu X, Xie X, Yang W, Zhang B.", "URL": "http://www.ncbi.nlm.nih.gov/pubmed/?term=32590058"}], "Frequent Amino Acids": "LGK", "Absent Amino Acids": "CDEHIMNOPQTUY", "Basic Residues": 4, "Acidic Residues": 0, "Hydrophobic Residues": 9, "Polar Residues": 7, "Positive Residues": 4, "Negative Residues": 0, "Similar Sequences": [{"SPADE_ID": "SPADE_UN_13446", "Similarity": 1.0, "Sequence": "GFGSLLGKALRLWKKVL"}, {"SPADE_ID": "SPADE_UN_13447", "Similarity": 1.0, "Sequence": "GFGSLLGKALRLWKKVL"}, {"SPADE_ID": "SPADE_UN_22428", "Similarity": 1.0, "Sequence": "RLWKIGKVLKWI"}]}}}